Annual EBITDA
-$298.59M$198.19M+39.89%
Summary
- Current Value
- As of today, MDGL annual EBITDA is -$298.59M, up +39.89% on
- Historical Performance
- MDGL annual EBITDA is down -1.87% over the past 3 years, down -45.05% over the past 5 years
- All-Time High Comparison
- MDGL annual EBITDA is currently -459.74% below its historical high of $83.00M set on
- 3-Year Low Comparison
- MDGL annual EBITDA is +39.89% above its 3-year low of -$496.78M reached on
- Sector Comparison
- MDGL annual EBITDA is higher than 4.20% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$298.59M | +39.9% | -1.9% | -45.0% | -754.0% | |
| Quarterly EBITDA | -$59.22M | +11.1% | +30.5% | +0.4% | -649.4% | |
| TTM EBITDA | -$298.59M | +39.9% | -1.9% | -44.8% | -754.0% | |
| Price | $424.98 | +24.5% | +55.8% | +271.6% | +139.5% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $958.40M | +432.1% | +100.0% | +100.0% | +6374.4% | |
| Annual EPS | -$12.85 | +41.3% | +25.4% | +1.9% | +60.5% | |
| -$300.10M | +39.7% | -2.2% | -45.5% | -713.3% | ||
| Annual Net Income | -$288.28M | +38.1% | +2.4% | -42.5% | -669.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$293.10M | N/A | -1.9% |
| 5Y | -$205.85M | N/A | -45.0% |
| All | $83.00M | -459.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$496.78M | +39.9% | |
| 5Y | -$496.78M | +39.9% | |
| All | -$496.78M | +39.9% |
EBITDA History
FAQ
What is the current annual EBITDA of MDGL?
As of today, MDGL annual EBITDA is -$298.59M
What is 1-year change in MDGL annual EBITDA?
MDGL annual EBITDA is up +39.89% year-over-year
What is 3-year change in MDGL annual EBITDA?
MDGL annual EBITDA is down -1.87% over the past 3 years
How far is MDGL annual EBITDA from its all-time high?
MDGL annual EBITDA is currently -459.74% below its historical high of $83.00M set on December 31, 2009
How does MDGL annual EBITDA rank versus sector peers?
MDGL annual EBITDA is higher than 4.20% of companies in Healthcare sector
When is MDGL next annual earnings release?
As of today, the next annual earnings release for MDGL has not been scheduled
Quarterly EBITDA
-$59.22M$54.40M+47.88%
Summary
- Current Value
- As of today, MDGL quarterly EBITDA is -$59.22M, up +47.88% on
- Historical Performance
- MDGL quarterly EBITDA is up +11.13% year-over-year, up +30.47% over the past 3 years
- All-Time High Comparison
- MDGL quarterly EBITDA is currently -149.86% below its historical high of $118.78M set on
- 3-Year Low Comparison
- MDGL quarterly EBITDA is +63.51% above its 3-year low of -$162.27M reached on
- Sector Comparison
- MDGL quarterly EBITDA is higher than 6.23% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$59.22M | +47.9% | +11.1% | +30.5% | +0.4% | |
| Annual EBITDA | -$298.59M | – | +39.9% | -1.9% | -45.0% | |
| TTM EBITDA | -$298.59M | +2.4% | +39.9% | -1.9% | -44.8% | |
| Price | $424.98 | -25.9% | +24.5% | +55.8% | +271.6% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $321.08M | +11.8% | +210.8% | +100.0% | +100.0% | |
| Quarterly EPS | -$2.57 | +49.5% | +5.3% | +48.5% | +32.8% | |
| -$59.61M | +47.7% | +11.0% | +30.1% | -0.1% | ||
| Quarterly Net Income | -$58.58M | +48.7% | +1.4% | +31.8% | +0.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$46.83M | -26.5% | |
| 3Y | -$46.83M | -26.5% | |
| 5Y | -$46.83M | -26.5% | |
| All | $118.78M | -149.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$113.62M | +47.9% | |
| 3Y | -$162.27M | +63.5% | |
| 5Y | -$162.27M | +63.5% | |
| All | -$162.27M | +63.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of MDGL?
As of today, MDGL quarterly EBITDA is -$59.22M
What is MDGL quarterly EBITDA most recent change?
MDGL quarterly EBITDA was up +47.88% on December 31, 2025
What is 1-year change in MDGL quarterly EBITDA?
MDGL quarterly EBITDA is up +11.13% year-over-year
How far is MDGL quarterly EBITDA from its all-time high?
MDGL quarterly EBITDA is currently -149.86% below its historical high of $118.78M set on September 30, 2009
How does MDGL quarterly EBITDA rank versus sector peers?
MDGL quarterly EBITDA is higher than 6.23% of companies in Healthcare sector
When is MDGL next earnings release?
The next earnings release for MDGL is on
TTM EBITDA
-$298.59M$7.42M+2.42%
Summary
- Current Value
- As of today, MDGL TTM EBITDA is -$298.59M, up +2.42% on
- Historical Performance
- MDGL TTM EBITDA is up +39.89% year-over-year, down -1.87% over the past 3 years
- All-Time High Comparison
- MDGL TTM EBITDA is currently -411.79% below its historical high of $95.77M set on
- 3-Year Low Comparison
- MDGL TTM EBITDA is +45.43% above its 3-year low of -$547.18M reached on
- Sector Comparison
- MDGL TTM EBITDA is higher than 4.30% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$298.59M | +2.4% | +39.9% | -1.9% | -44.8% | |
| Annual EBITDA | -$298.59M | – | +39.9% | -1.9% | -45.0% | |
| Quarterly EBITDA | -$59.22M | +47.9% | +11.1% | +30.5% | +0.4% | |
| Price | $424.98 | -25.9% | +24.5% | +55.8% | +271.6% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $958.40M | +29.4% | +432.1% | +100.0% | +100.0% | |
| TTM EPS | -$12.86 | +1.1% | +41.8% | +25.3% | +1.7% | |
| -$300.10M | +2.4% | +39.7% | -2.2% | -45.2% | ||
| TTM Net Income | -$288.28M | +0.3% | +38.1% | +2.4% | -42.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$298.59M | at high | |
| 3Y | -$293.10M | N/A | -1.9% |
| 5Y | -$206.20M | N/A | -44.8% |
| All | $95.77M | -411.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$496.78M | N/A | +39.9% |
| 3Y | -$547.18M | +45.4% | |
| 5Y | -$547.18M | +45.4% | |
| All | -$547.18M | +45.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of MDGL?
As of today, MDGL TTM EBITDA is -$298.59M
What is MDGL TTM EBITDA most recent change?
MDGL TTM EBITDA was up +2.42% on December 31, 2025
What is 1-year change in MDGL TTM EBITDA?
MDGL TTM EBITDA is up +39.89% year-over-year
How far is MDGL TTM EBITDA from its all-time high?
MDGL TTM EBITDA is currently -411.79% below its historical high of $95.77M set on March 31, 2010
How does MDGL TTM EBITDA rank versus sector peers?
MDGL TTM EBITDA is higher than 4.30% of companies in Healthcare sector
When is MDGL next earnings release?
The next earnings release for MDGL is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- MDGL Official Website www.madrigalpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
- MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
- MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl